MedPath

TRV-chair vs Manual Repositioning Maneuver in Treatment of Benign Paroxysmal Positional Vertigo

Not Applicable
Completed
Conditions
BPPV
Interventions
Procedure: Manual repositioning maneuver
Device: TRV-chair
Registration Number
NCT03871413
Lead Sponsor
Aalborg University Hospital
Brief Summary

Comparison of treatment efficacy of a mechanical rotational chair (TRV-chair) vs. manual repositioning maneuvers in BPPV

Detailed Description

Open-label, randomized controlled trial comparing manual repositioning maneuvers with a mechanical rotational chair (TRV-chair) in diagnosing and treating BPPV. Patients with suspected BPPV will be randomized to either manual repositioning maneuvers or the TRV-chair.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • Characteristic (for BPPV) positional nystagmus
  • Positive Dix-Hallpike
  • Positive supine roll test
  • Medical history compatible with BPPV
Exclusion Criteria
  • Treatment in TRV-chair within the last 6 months
  • Exclusion of BPPV diagnosis
  • Lack of treatment cooperation
  • Known cerebral aneurism or cerebral hemorrhage
  • Diagnosed and treated for BPPV within the past month
  • Treatment with sedating anti-histamines within the past 7 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Manual repositioning maneuverManual repositioning maneuverDiagnostics and treatment of BPPV with manual repositioning maneuvers. In case of posterior canal involvement, Epley's maneuver will be used. In case of horizontal canal involvement, the log roll maneuver will be used.
Treatment in mechanical rotational chair (TRV-chair)TRV-chairDiagnostics and treatment of BPPV with the use of a TRV chair. In case of posterior canal involvement, Epley's maneuver will be used with the addition of 10 kinetic impulses in each position. In case of horizontal canal involvement, the log roll maneuver will be used with the addition of 10 kinetic impulses in each position.
Primary Outcome Measures
NameTimeMethod
Number of treatments2 years

Number of treatment necessary to achieve resolution of vertigo and nystagmus

Treatment success after first treatment2 years

Number of subjects achieving resolution of vertigo and nystagmus after one treatment

Secondary Outcome Measures
NameTimeMethod
Dizziness Handicap Inventory (DHI) questionnaire2 years

Comparison of pre-treatment score and post-treatment score

Adverse events2 years

Registration of adverse events

Trial Locations

Locations (1)

Department of Otolaryngology, Head & Neck Surgery and Audiology

🇩🇰

Aalborg, North Denmark Region, Denmark

© Copyright 2025. All Rights Reserved by MedPath